603 related articles for article (PubMed ID: 32434704)
1. The visceral adiposity index is a predictor of incident nonalcoholic fatty liver disease: A population-based longitudinal study.
Okamura T; Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukui M
Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):375-383. PubMed ID: 32434704
[TBL] [Abstract][Full Text] [Related]
2. Visceral Adiposity Index is a predictor of incident colorectal cancer: a population-based longitudinal study.
Okamura T; Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukui M
BMJ Open Gastroenterol; 2020 Jun; 7(1):. PubMed ID: 32595114
[TBL] [Abstract][Full Text] [Related]
3. The Visceral Adiposity Index Is a Predictor of Incident Chronic Kidney Disease: A Population-Based Longitudinal Study.
Bamba R; Okamura T; Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukui M
Kidney Blood Press Res; 2020; 45(3):407-418. PubMed ID: 32224619
[TBL] [Abstract][Full Text] [Related]
4. Visceral adiposity index as a predictor of NAFLD: A prospective study with 4-year follow-up.
Xu C; Ma Z; Wang Y; Liu X; Tao L; Zheng D; Guo X; Yang X
Liver Int; 2018 Dec; 38(12):2294-2300. PubMed ID: 30099825
[TBL] [Abstract][Full Text] [Related]
5. Visceral adiposity index is not a predictor of liver histology in patients with non-alcoholic fatty liver disease.
Vongsuvanh R; George J; McLeod D; van der Poorten D
J Hepatol; 2012 Aug; 57(2):392-8. PubMed ID: 22521350
[TBL] [Abstract][Full Text] [Related]
6. Visceral Adiposity Index As a Practical Tool in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.
Vural Keskinler M; Mutlu HH; Sirin A; Erkalma Senates B; Colak Y; Tuncer I; Oguz A
Metab Syndr Relat Disord; 2021 Feb; 19(1):26-31. PubMed ID: 32898457
[No Abstract] [Full Text] [Related]
7. Short sleep duration is a risk of incident nonalcoholic fatty liver disease: a population-based longitudinal study.
Okamura T; Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukui M
J Gastrointestin Liver Dis; 2019 Mar; 28(1):73-81. PubMed ID: 30851175
[TBL] [Abstract][Full Text] [Related]
8. Visceral adiposity index and longitudinal risk of incident metabolic syndrome: Korean genome and epidemiology study (KoGES).
Jung JY; Ryoo JH; Oh CM; Choi JM; Chung PW; Hong HP; Park SK
Endocr J; 2020 Jan; 67(1):45-52. PubMed ID: 31611471
[TBL] [Abstract][Full Text] [Related]
9. [Relationship of visceral adiposity index with serum aminotransferase and nonalcoholic fatty liver disease in patients with sleep apnea].
Qi J; Lin Q; Lin X; Chen X
Zhonghua Yi Xue Za Zhi; 2015 Nov; 95(42):3420-3. PubMed ID: 26813130
[TBL] [Abstract][Full Text] [Related]
10. Creatinine-to-bodyweight ratio is a predictor of incident non-alcoholic fatty liver disease: A population-based longitudinal study.
Okamura T; Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukui M
Hepatol Res; 2020 Jan; 50(1):57-66. PubMed ID: 31692179
[TBL] [Abstract][Full Text] [Related]
11. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
[TBL] [Abstract][Full Text] [Related]
12. Lipid accumulation product and triglycerides/glucose index are useful predictors of insulin resistance.
Mazidi M; Kengne AP; Katsiki N; Mikhailidis DP; Banach M
J Diabetes Complications; 2018 Mar; 32(3):266-270. PubMed ID: 29395839
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease.
Cen C; Wang W; Yu S; Tang X; Liu J; Liu Y; Zhou L; Yu J; Zheng S
Hepatol Int; 2020 Sep; 14(5):808-816. PubMed ID: 32572817
[TBL] [Abstract][Full Text] [Related]
14. Positively increased visceral adiposity index in hyperuricemia free of metabolic syndrome.
Gu D; Ding Y; Zhao Y; Miao S; Qu Q
Lipids Health Dis; 2018 May; 17(1):101. PubMed ID: 29734946
[TBL] [Abstract][Full Text] [Related]
15. The Triglyceride and Glucose Index Is a Predictor of Incident Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study.
Kitae A; Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukui M
Can J Gastroenterol Hepatol; 2019; 2019():5121574. PubMed ID: 31687367
[TBL] [Abstract][Full Text] [Related]
16. Can High Visceral Adiposity Index Be a Risk Factor for Sexual Dysfunction in Sexually Active Men?
Bolat MS; Kocamanoglu F; Ozbek ML; Buyukalpelli R; Asci R
J Sex Med; 2020 Oct; 17(10):1926-1933. PubMed ID: 32712095
[TBL] [Abstract][Full Text] [Related]
17. Remnant cholesterol, stronger than triglycerides, is associated with incident non-alcoholic fatty liver disease.
Cheng Y; Zhang Q; Li H; Zhou G; Shi P; Zhang X; Guan L; Yan F; Xu C
Front Endocrinol (Lausanne); 2023; 14():1098078. PubMed ID: 37214248
[TBL] [Abstract][Full Text] [Related]
18. Utility of three novel insulin resistance-related lipid indices for predicting type 2 diabetes mellitus among people with normal fasting glucose in rural China.
Wang B; Zhang M; Liu Y; Sun X; Zhang L; Wang C; Li L; Ren Y; Han C; Zhao Y; Zhou J; Pang C; Yin L; Feng T; Zhao J; Hu D
J Diabetes; 2018 Aug; 10(8):641-652. PubMed ID: 29322661
[TBL] [Abstract][Full Text] [Related]
19. Visceral adiposity index is associated with benign prostatic enlargement in non-diabetic patients: a cross-sectional study.
Besiroglu H; Ozbek E; Dursun M; Otunctemur A
Aging Male; 2018 Mar; 21(1):40-47. PubMed ID: 28823197
[TBL] [Abstract][Full Text] [Related]
20. PEDIATRIC VISCERAL ADIPOSITY INDEX ADAPTATION CORRELATES WITH HOMA-IR, MATSUDA, AND TRANSAMINASES.
Hernández MJG; Klünder M; Nieto NG; Alvarenga JCL; Gil JV; Huerta SF; Siccha RQ; Hernandez J
Endocr Pract; 2018 Mar; 24(3):294-301. PubMed ID: 29547047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
